Important information COVID-19

Congress Now Virtual

New date : August 20-23, 2020

Friday August 21, Barcelona

01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting room 131‑132
Transgender therapy and relationship with bone disorders
Chairperson: Bruno Muzzi Camargos
Guidelines for hormonal therapy on transgender patients Ariana Sierra Osorio
From man to woman and from woman to man: Does it matter? Andres Coy
Densitometric acquisition, analysis and reporting Bruno Muzzi Camargos
Recommendations to maintain bone health on transgender patients Adriana Medina Orjuella
Meeting room 127‑128
Vitamin D deficiency and rheumatic diseases
Chairperson: Panagiotis Athanassiou
Vitamin D deficiency and autoimmunity Ifigenia Kostoglou‑Athanassiou
Vitamin D deficiency and rheumatoid arthritis Yannis Dionyssiotis
Vitamin D deficiency and systemic lupus erythematosus Panagiotis Athanassiou
Vitamin D receptor polymorphisms and autoimmune diseases Lambros Athanassiou
Meeting room 133‑134
Global Impact of Bone Health TeleECHO: The Prototype for Technology Enabled Collaborative Learning for Skeletal Healthcare
Chairperson: E. Michael Lewiecki
Introduction and Background of Bone Health TeleECHO E. Michael Lewiecki
National University of Ireland Galway Bone Health TeleECHO John J. Carey
Bone Health TeleECHO Moscow Zhanna Belaya
Rare Bone Disease TeleECHO Kassim Javaid
Panel discussion with all faculty
Meeting room 118
Artificial Intelligence (AI) in Musculoskeletal Imaging – A Paradigm Shift ‘ante portas’?
Chairperson: Hans Peter Dimai
AI in various modalities of musculoskeletal imaging (radiography, DXA, CT, MRT) Ronald M. Summers
Knee osteoarthritis assessment by AI increases physicians’ agreement rate and accuracy Stefan Nehrer
Questions and Answers
Meeting room 119
Managing fracture risk in primary care: roles and requirements
Chairperson: Zoe Paskins
Current challenges for primary care osteoporosis management Zoe Paskins
What osteoporosis care looks like in current UK general practice Elizabeth Cottrell
Primary care and the management of special groups at risk of fracture Elizabeth Cottrell
How primary care osteoporosis management can be improved John Edwards
Summing up: Challenges and opportunities for better integration of primary and secondary care Zoe Paskins
Close Zoe Paskins
Meeting room 120
Nationwide identification of vertebral fragility fractures: Collaborating with Radiology
Chairperson: Bo Abrahamsen
Collaboration for better patient outcomes in vertebral fracture Jill Griffin
National audit on the reporting of incidentally found vertebral fractures in routine radiology practice Nadia Mahmood
Evaluation of the identification of vertebral fractures within fracture liaison services- looking to the future Kassim Javaid
Evaluating the demand on fracture liaison services with effective identification of vertebral fractures Helen Glenn
Meeting room 121
Winning the political case for change – launch of a policy toolkit for osteoporosis and fragility fractures
Chairperson: Ed Harding
Welcome and introduction to the project Ed Harding
Critical challenges in osteoporosis and fragility fracture care Cyrus Cooper
Policy actions needed to improve prevention and care of osteoporosis and fragility fractures John Bowis
Next steps for the network Ed Harding
Discussion and wrap-up Ed Harding
Meeting room 122
Targeting bone and muscle: Novel therapeutic approaches to osteosarcopenia
Chairperson: Serge Ferrari
RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass from mice to humans Nicolas Bonnet
Old and new roles of amino acids and amino butyric acids in musculoskeletal diseases Marco Brotto
Fat as a therapeutic target in osteosarcopenia Gustavo Duque
Meeting room 123
Joint Symposium of the IOF Skeletal Rare Diseases Working Group (SRD-WG) and the a European Reference Network on Rare Bone Diseases (ERN-BOND)
Chairperson: Maria Luisa Brandi
Diversity on the pathophysiology of increased bone fragility in rare bone diseases Naveen Hamdy
Quality of bone in Osteogenesis Imperfecta patients Luca Sangiorgi
08.00 - 09.00
Meeting room 124‑125
Gut microbiota (GMB) and osteoarthritis (OA) management: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing.
Chairperson: Sansin Tüzün
Introduction René Rizzoli
Gut microbiota and inflammation Claudio Franceschi
Role of gut microbiota in non-communicable disease and osteoarthritis management René Rizzoli
Discussion René Rizzoli
Panel: Islene Araujo de Carvalho, Francis Berenbaum, Emmanuel Biver, Maria Luisa Brandi, Philip Calder, Vincenzo Castronovo, Etienne Cavalier, Antonio Cherubini, Elaine M. Dennison, Claudio Franceschi, Nicholas R. Fuggle, Andrea Laslop, Pierre Miossec, Jean‑Yves Reginster, René Rizzoli, Thierry Thomas, Sansin Tüzün, Nicola Veronese
09.00 - 10.30
Auditorium A
SCIENTIFIC SESSION I
Chairpersons: Cyrus Cooper, René Rizzoli
09.00
Auditorium A
Plenary Lecture 1
Transient treatment discontinuation : pros and cons Michael R. McClung
09.30
Auditorium A
Oral communication selected from abstracts
09.30
Auditorium A
OC1
‣ EFFICACY AND SAFETY OF ROMOSOZUMAB AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND MILD-TO-MODERATE CHRONIC KIDNEY DISEASE
Presenting author: B. Langdahl
Authors: D. Miller, J. Adachi, B.‑H. Albergaria, A. M. Cheung, A. Chines, E. Gielen, A. Miyauchi, M. Oates, I. R. Reid, N. Ruiz Santiago, M. Vanderkelen, W. Yang, Z. Yu
09.40
Auditorium A
OC2
‣ ROMOSOZUMAB AFTER DENOSUMAB IMPROVES LUMBAR SPINE AND MAINTAINS TOTAL HIP BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS
Presenting author: M. R. McClung
Authors: M. A. Bolognese, J. P. Brown, J.‑Y. Reginster, B. L. Langdahl, N. Ruiz Santiago, Y. Shi, M. Rojeski, J. Timoshanko, C. Libanati, H. Kassahun, M. Oates
09.50
Auditorium A
OC3
‣ VERTEBRAL FRACTURES BEFORE, DURING AND AFTER DENOSUMAB. A RETROSPECTIVE STUDY OF 858 CASES
Presenting author: P. Burckhardt
Authors: O. Lamy, T. H. Buclin, M. Faouzi, D. Aeberli, F. Cattaneo, J. Dudler, M. Felder, D. Frey, P. Hasler, H. J. Häuselmann, S. Jehle‑Kunz, I. Krull, T. H. Lehmann, K. Lippuner, C. Meier, U. Moser, M. Oehri, A. Rohrer, F. Tanzi, M. Toniolo, B. Uebelhart, L. Wildi, D. Wildpaner
10.00
Auditorium A
OC4
‣ DIFFERENTIAL EFFECTS OF ABALOPARATIDE AND TERIPARATIDE ON CORTICAL VOLUMETRIC BMD AND BONE STRENGTH INDICES IN THE PROXIMAL FEMUR BY DXA-BASED 3D MODELING
Presenting author: R. Winzenrieth
Authors: S. Ominsky, Y. Wang, L. Humbert, J. Weiss
10.10
Auditorium A
OC5
‣ FRACTURE RISK REDUCTION BY ANTI-OSTEOPOROSIS PHARMACOTHERAPY ACCORDING TO BASELINE RISK FACTORS AMONG POSTMENOPAUSAL WOMEN: METAREGRESSION ANALYSES OF RANDOMISED TRIALS
Presenting author: M. N. Händel
Authors: I. Cardoso, C. Von Bülow, J. F. Rohde, A. Ussig, S. M. Nielsen, R. Christensen, B. Langdahl, T. Thomas, J.‑J. Body, M. L. Brandi, A. Diez‑Perez, P. Hadji, M. K. Javaid, W. F. Lems, X. Nogués, C. Roux, S. Minisola, A. Kurth, S. Ferrari, D. Prieto‑Alhambra, B. Abrahamsen
10.20
Auditorium A
OC6
‣ BUROSUMAB IMPROVES BIOCHEMICAL, SKELETAL, AND CLINICAL FEATURES OF TUMOR-INDUCED OSTEOMALACIA (TIO) SYNDROME
Presenting author: S. Jan de Beur
Authors: P. D. Miller, T. J. Weber, M. Peacock, K. L. Insogna, R. Kumar, D. Luca, T. Cimms, M. S. Roberts, T. O. Carpenter
10.30 - 12.10
Auditorium A
SCIENTIFIC SESSION II
Chairpersons: Jean‑Yves Reginster, John A. Kanis
10.30
Auditorium A
Presentation of the ESCEO-IOF Herbert Fleisch Medal
René Rizzoli
10.35
Auditorium A
Presentation of the IOF President's Award
Cyrus Cooper
10.40
Auditorium A
Plenary Lecture 2
Differences in clinical guidelines Eugene McCloskey
11.10
Auditorium A
Oral communication selected from abstracts
11.10
Auditorium A
OC7
‣ TEMPORAL TRENDS AND FACTORS ASSOCIATED WITH BISPHOSPHONATE DISCONTINUATION AND RESTART
Presenting author: G. Adami
Authors: A. Jaleel, J. C. Curtis, E. Delzell, R. Chen, H. Yun, S. Daigle, T. Arora, M. I. Danila, N. C. Wright, S. M. Cadarette, A. S. Mudano, J. Foster, K. G. Saag
11.20
Auditorium A
OC8
‣ MACROBIOTIC DIETS, PLANT-BASED DIETS, VEGETARIANISM, VEGANISM AND BONE HEALTH: A SYSTEMATIC REVIEW AND META-ANALYSES
Presenting author: I. Iguacel
Author: L. A. Moreno
11.30
Auditorium A
OC9
‣ DISEASE PHENOTYPE AS A PREDICTOR OF TREATMENT RESPONSE IN OSTEOARTHRITIS: RESULTS FROM A PHASE II CLINICAL TRIAL OF THE FIRST-IN-CLASS IMIDAZOLINE-2 RECEPTOR LIGAND CR4056
Presenting author: G. Giacovelli
Authors: L. C. Rovati, N. Brambilla, T. Blicharski, J. Connell, C. Vitalini, A. Bonazzi, F. Girolami, M. D'Amato
11.40
Auditorium A
OC10
‣ THE NOVEL, INTRA-ARTICULAR CLK/DYRK1A INHIBITOR LORECIVIVINT (SM04690), A WNT PATHWAY MODULATOR, IMPROVED RESPONDER OUTCOMES IN SUBJECTS WITH KNEE OSTEOARTHRITIS: A POST HOC ANALYSIS FROM A PHASE 2B TRIAL
Presenting author: J. Tambiah
Authors: S. Kennedy, C. Swearingen, Y. Yazici
11.50
Auditorium A
OC11
‣ EFFICACY AND SAFETY OF AN INTRA-ARTICULAR INJECTION OF JTA-004, A NOVEL ENHANCED PROTEIN SOLUTION, IN KNEE OSTEOARTHRITIS PAIN: A RANDOMISED, DOUBLE-BLIND CONTROLLED PHASE II/III STUDY
Presenting author: O. Godeaux
Authors: M. Bettonville, M. Léon, J. Margaux, D. Urbin‑Choffray, E. Theunissen, T. Besse‑Hammer, Y. Fortems, S. Verlinden, A.‑S. Delmarcelle, J.‑F. Kaux
12.00
Auditorium A
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
Jean‑Yves Reginster
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Meeting room 131‑132
Discussion of complex osteoporotic cases
Adolfo Diez‑Perez
Meeting room 133‑134
Management of CKD-MBD
Jorge Cannata Andia
Meeting room 118
Nutritional approach of osteoporosis prevention
Stefania Maggi
Meeting room 119
GIOP : what to do ?
Bernard Cortet
14.00 - 15.00
Meeting room 124‑125
Alternative treatments for osteoarthritis: stem cells, platelet-rich plasma, autologous chondrocyte transplantation, ...: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: Willem Lems, Andrew Price
Introduction and scope of the problem Emmanuel Maheu
Role of surgical regenerative therapies in the management of knee osteoarthritis Willem Lems
Role of "alternative" treatments of knee osteoarthritis Nicholas R. Fuggle
Discussion Andrew Price
Panel: Francis Berenbaum, Jaime Branco, Maria Luisa Brandi, Olivier Bruyère, Philip Conaghan, Cyrus Cooper, Bernard Cortet, Maurizio Cutolo, Nicholas R. Fuggle, Germain Honvo, Jean‑François Kaux, Willem Lems, Emmanuel Maheu, Radmila Matijevic, Richard Oreffo, Andrew Price, Jean‑Yves Reginster, Roland Roth, Thierry Thomas, Nicola Veronese
14.00 - 15.00
Meeting room 127‑128
Is there a role for MHT in the management of post-menopausal osteoporosis? Outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and under the auspices of the International Osteoporosis Foundation (IOF).
Chairpersons: Maria Luisa Brandi, Tim Hillard
Welcome and scope of the problem Antonio Cano
Effects of MHT on bone: What, when, how? Andrea Genazzani
Risk/benefit ratio of MHT before and after 60 years Serge Rozenberg
Discussion (Leader: Serge Rozenberg): All participants of the Working Group
Conclusions Antonio Cano
Panel: Mylène Aubertin‑Leheudre, Maria Luisa Brandi, Antonio Cano, Peter Collins, Cyrus Cooper, Andrea Genazzani, Nicholas Harvey, Tim Hillard, John A. Kanis, Jean‑Marc Kaufman, Irene Lambrinoudaki, Andrea Laslop, Daniel Prieto‑Alhambra, Jean‑Yves Reginster, René Rizzoli, Giuseppe Rosano, Serge Rozenberg, Florence Trémollières
14.00 - 15.00
Poster Area
Poster Viewing Session I
14.00 - 15.10
Podium
Oral presentation of selected posters
Chairperson: Claudia Campusano
14.00
Podium
P906
‣ LONG-TERM SAFETY IN ADULTS WITH X-LINKED HYPOPHOSPHATEMIA (XLH) TREATED WITH BUROSUMAB, A FULLY HUMAN MONOCLONAL ANTIBODY AGAINST FGF23: FINAL RESULTS OF A PHASE 3 TRIAL
Presenting author: M. L. Brandi
Authors: A. A. Portale, T. O. Carpenter, K. Briot, E. A. Imel, P. Kamenicky, T. J. Weber, P. Pitukcheewanont, H. I. Cheong, S. Jan de Beur, Y. Imanishi, N. Ito, R. Lachmann, H. Tanaka, F. Perwad, L. Zhang, A. Skrinar, L. Rees, K. Insogna
14.07
Podium
P1133
‣ DOES ENDOGENOUS INFLAMMATION EXPLAIN ETHNIC VARIATION IN BONE MINERAL DENSITY? RESULTS FROM THE SABRE COHORT STUDY
Presenting author: R. Durdin
Authors: C. Parsons, E. M. Dennison, S. Williams, T. Tillin, N. Chaturvedi, C. Cooper, N. C. Harvey, K. Ward
14.14
Podium
P581
‣ AN INTERACTIVE BENEFITS AND BUDGET IMPACT CALCULATOR TO ESTIMATE POTENTIAL EFFECTS OF FRACTURE LIAISON SERVICES
Presenting author: R. Pinedo‑Villanueva
Authors: A. Sami, S. Kolovos, E. Burn, M. Fujita, P. Halbout, C. Cooper, M. K. Javaid
14.21
Podium
P236
‣ PHASE I/III STUDY TO CONFIRM BIOEQUIVALENCE AND SAFE SWITCHING OF PROPOSED BIOSIMILAR DENOSUMAB IN POSTMENOPAUSAL OSTEOPOROSIS
Presenting author: R. Eastell
Authors: J.‑J. Body, C. Nie, B. Vogg
14.28
Podium
P255
‣ SARCOPENIA AND HEALTH-RELATED OUTCOMES: AN UMBRELLA REVIEW OF OBSERVATIONAL STUDIES
Presenting author: N. Veronese
Authors: J. Demurtas, P. Soysal, L. Smith, O. Bruyère, J.‑Y. Reginster, C. Beaudart, C. Cooper, M. Mirko, S. Maggi
14.35
Podium
P463
‣ HORMONE THERAPY REDUCES THE RISK OF FRACTURE REGARDLESS OF BASELINE FRACTURE RISK – RESULTS FROM THE WOMEN’S HEALTH INITIATIVE HORMONE THERAPY TRIALS
Presenting author: M. Lorentzon
Authors: H. Johansson, N. C. Harvey, E. Liu, C. Crandall, E. V. McCloskey, J. A. Kanis
14.42
Podium
P559
‣ DISABILITY-ADJUSTED LIFE YEARS RELATED TO FRAGILITY FRACTURES
Presenting author: F. Borgström
Authors: N. V. Norton, L. Karlsson, G. Ortsäter, N. C. Harvey, E. V. McCloskey, J. A. Kanis
14.49
Podium
P1265
‣ INTEGRATED SAFETY SUMMARY OF THE NOVEL, INTRA-ARTICULAR AGENT LORECIVIVINT (LOR; SM04690), A CLK/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, IN SUBJECTS WITH KNEE OSTEOARTHRITIS
Presenting author: N. Lane
Authors: I. Simsek, C. Swearingen, S. Kennedy, J. Tambiah, C. Damatarca, Y. Yazici, M. Hochberg
14.56
Podium
P590
‣ INTRA-ARTICULAR CORTICOSTEROID KNEE INJECTION INDUCES A REDUCTION IN MENISCAL THICKNESS WITH NO TREATMENT EFFECT ON CARTILAGE VOLUME: A CASE-CONTROL STUDY
Presenting author: J.‑P. Pelletier
Authors: J.‑P. Raynauld, F. Abram, M. Dorais, P. Paiement, J. Martel‑Pelletier
15.03
Podium
P876
‣ ASSOCIATION BETWEEN SARC-F AND QUALITY OF LIFE MEASURED WITH THE SARQOL® QUESTIONNAIRE IN OLDER, COMMUNITY-DWELLING SUBJECTS FROM THE SARCOPHAGE COHORT
Presenting author: M. Locquet
Authors: A. Geerinck, C. Beaudart, J.‑Y. Reginster, O. Bruyère
15.00 - 17.00
Auditorium A
SCIENTIFIC SESSION III
Chairpersons: Nicholas Harvey, Bess Dawson‑Hughes
15.00
Auditorium A
Plenary Lecture 3
Bone turnover markers in clinical practice Roland D. Chapurlat
15.30
Auditorium A
Oral communication selected from abstracts
15.30
Auditorium A
OC12
‣ CONFIRMED AND SEVERE SARCOPENIA BY EWGSOP2 PREDICT 10-YEAR FRACTURE RISK INDEPENDENT OF FRAX, FALLS AND BMD IN THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY: A META-ANALYSIS
Presenting author: N. C. Harvey
Authors: E. Orwoll, T. Kwok, M. K. Karlsson, B. E. Rosengren, E. Ribom, J. A. Cauley, P. M. Cawthon, K. Ensrud, E. Liu, A. J. Cruz Jentoft, C. Cooper, J. A. Kanis, M. Lorentzon, C. Ohlsson, D. Mellström, H. Johansson, E. V. McCloskey
15.40
Auditorium A
OC13
‣ MUSCLE DENSITY, BUT NOT SIZE, CORRELATES WELL WITH MUSCLE PERFORMANCE
Presenting author: L. Wang
Authors: Y. Yin, G. Guglielmi, X. Cheng, G. M. Blake, K. Engelke
15.50
Auditorium A
OC14
‣ THE MULTIDIMENSIONAL PROGNOSTIC INDEX PREDICTS FALLS IN OLDER PEOPLE: AN 8-YEAR LONGITUDINAL COHORT STUDY OF THE OSTEOARTHRITIS INITIATIVE
Presenting author: N. Veronese
Authors: G. Siri, A. Cella, S. Maggi, E. Zigoura, M. Puntoni, L. Smith, C. Musacchio, A. Barone, C. Sabbà, F. Vallone, A. Pilotto
16.00
Auditorium A
OC15
‣ 5-YEAR ADVERSE OUTCOMES OF SARCOPENIA DIAGNOSED ACCORDING TO SIX DIFFERENT DEFINITIONS
Presenting author: L. Lengelé
Authors: C. Beaudart, M. Locquet, J.‑Y. Reginster, O. Bruyère
16.10
Auditorium A
OC16
‣ LEVEL AND CHANGE IN SARCOPENIA COMPONENTS PREDICT ADVERSE HEALTH OUTCOMES: FINDINGS FROM THE HEALTH, AGING AND BODY COMPOSITION STUDY
Presenting author: L. D. Westbury
Authors: H. E. Syddall, N. R. Fuggle, E. M. Dennison, J. A. Cauley, E. J. Shiroma, R. A. Fielding, A. B.  Newman, C. Cooper
16.20
Auditorium A
OC17
‣ RELATIONSHIP BETWEEN OBESITY AND RISK OF MAJOR OSTEOPOROTIC FRACTURE IN POSTMENOPAUSAL WOMEN: TAKING FRAILTY INTO CONSIDERATION
Presenting author: G. Li
Authors: Z. Li, L. Thabane, J. Adachi
16.30
Auditorium A
Plenary Lecture 4
Bone fragility: beyond bone loss Serge Ferrari
15.00 - 16.45
Meeting room 127‑128
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
‣ Musculoskeletal diseases: diagnosis, management and consequences
Chairpersons: Philippe Halbout, Jean‑Yves Reginster, Famida Jiwa
15.03
Meeting room 127‑128
P1081
‣ THE BELGIAN BONE CLUB 2020 GUIDELINES FOR THE MANAGEMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
Presenting author: D. Sanchez‑Rodriguez
Authors: P. Bergmann, J.‑J. Body, E. Cavalier, E. Gielen, S. Goemaere, B. Lapauw, M. R. Laurent, S. Rozenberg, G. Honvo, C. Beaudart, O. Bruyère
15.11
Meeting room 127‑128
P159
‣ THE TRABECULAR BONE SCORE IS ASSOCIATED WITH BONE MINERAL DENSITY, AND MARKERS OF BONE TURNOVER IN NON-OBESE SUBJECTS: THE BUSHEHR ELDERLY HEALTH (BEH) PROGRAM
Presenting author: A. Ostovar
Authors: S. Gharibzadeh, N. Fahimfar, M. Sanjari, G. Shafiee, R. Heshmat, N. Mehrdad, F. Razi, P. Khashayar, A. Raiesei, I. Nabipour, B. Larijani
15.19
Meeting room 127‑128
P224
‣ FREQUENCY OF DEFICIENCY AND INSUFFICIENCY OF VITAMIN D IN 547 PREGNANT BULGARIAN WOMEN (SCREENING OF BULGARIAN SOCIETY OF ENDOCRINOLOGY)
Presenting author: A.‑M. Borissova
Authors: B. Cvetanova, L. Dakovska, E. Mihailova, M. Vukov
15.27
Meeting room 127‑128
P225
‣ DISCONTINUATION OF DENOSUMAB RESULTS IN RAPID INCREASE OF BONE RESORPTION AND LOSS OF BONE MINERAL DENSITY GAIN
Presenting author: M. Cokolic
Author: M. Krajnc
15.35
Meeting room 127‑128
P327
‣ CONSERVATIVE OR SURGICAL TREATMENT IN QUALITY OF LIFE PERCEPTION OF PATIENTS AFTER 3 YEARS OF VERTEBRAL OSTEOPOROTIC FRACTURE
Presenting author: A. Olascoaga‑Gómez de León
Authors: R. Coronado‑Zarco, P. R. Piña‑Navarro
15.45
Meeting room 127‑128
Presentation of the IOF Committee of National Societies Medal
Jean‑Yves Reginster
15.55
Meeting room 127‑128
P515
‣ PERFORMANCE OF THE “YUBI-WAKKA (FINGER-RING)” TEST AS SELF-SCREENING METHOD FOR SARCOPENIA USING THE SARCOPHAGE, BELGIAN COHORT STUDY
Presenting author: C. Beaudart
Authors: M. Locquet, L. Lengelé, J.‑Y. Reginster, O. Bruyère
16.03
Meeting room 127‑128
P533
‣ CUSTOMIZED POSTURAL REBALANCING IN OSTEOPENIC SUBJECTS WITH PAINFUL DEVIATIONS OF THE SPINE: PRELIMINARY FUNCTIONAL AND DENSITOMETRIC RESULTS
Presenting author: L. Cavalli
Authors: G. Malevolti, E. Martinelli, M. L. Brandi
16.11
Meeting room 127‑128
P581
‣ AN INTERACTIVE BENEFITS AND BUDGET IMPACT CALCULATOR TO ESTIMATE POTENTIAL EFFECTS OF FRACTURE LIAISON SERVICES
Presenting author: R. Pinedo‑Villanueva
Authors: A. Sami, S. Kolovos, E. Burn, M. Fujita, P. Halbout, C. Cooper, M. K. Javaid
16.19
Meeting room 127‑128
P727
‣ OVERLAP BETWEEN OSTEOSARCOPENIA AND FRAILTY AND THEIR ASSOCIATION WITH POOR HEALTH CONDITIONS: THE BUSHEHR ELDERLY HEALTH (BEH) PROGRAM
Presenting author: G. Shafiee
Authors: R. Heshmat, A. Ostovar, N. Fahimfar, F. Sharifi, S. Gharibzadeh, I. Nabipour, B. Larijani
16.27
Meeting room 127‑128
P826
‣ PHARMACOGENETICS OF RESPONSE TO BISPHOSPHONATE TREATMENT IN POSTMENOPAUSAL OSTEOPOROSIS
Presenting author: P. Marozik
Authors: V. Alekna, E. Rudenko, M. Tamulaitiene, A. Rudenka, V. Samokhovec, K. Kobets
16.35
Meeting room 127‑128
P387
‣ HIP AREAL BMD BY DXA (ABMD) AND HIP VOLUMETRIC BMD BY 3D MODELING OF HIP DXA (VBMD) ARE HIGHLY CORRELATED IN BOTH FRACTURE PREVALENT AND FRACTURE NON-PREVALENT OSTEOPOROSIS PATIENTS
Presenting author: D. Kendler
Authors: A. Mann, C. Kam, V. Singh, R. Winzenrieth, M. Almohaya